461P Evaluation of PGN-EDODM1: FREEDOM-DM1 and FREEDOM2-DM1 clinical trials in myotonic dystrophy type 1
Neuromuscular Disorders · 2024-10 · 43 · 104441.536
DOI: 10.1016/j.nmd.2024.07.545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuromuscular Disorders, 2024-10. Verfasst von J. Larkindale und 8 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Larkindale, J., Shoskes, J., Garg, B., Song, G., Lonkar, P., Babcock, S., Vacca, S., Yu, S., & Mellion, M. (2024). 461P Evaluation of PGN-EDODM1: FREEDOM-DM1 and FREEDOM2-DM1 clinical trials in myotonic dystrophy type 1. Neuromuscular Disorders, 43, 104441.536. https://doi.org/10.1016/j.nmd.2024.07.545
Vancouver
Larkindale J, Shoskes J, Garg B, Song G, Lonkar P, Babcock S, et al. 461P Evaluation of PGN-EDODM1: FREEDOM-DM1 and FREEDOM2-DM1 clinical trials in myotonic dystrophy type 1. Neuromuscular Disorders. 2024;43:104441.536. doi:10.1016/j.nmd.2024.07.545
BibTeX
@article{Larkindale2024,
author = {Larkindale, J. and Shoskes, J. and Garg, B. and Song, G. and Lonkar, P. and Babcock, S. and Vacca, S. and Yu, S. and Mellion, M.},
title = {461P Evaluation of PGN-EDODM1: FREEDOM-DM1 and FREEDOM2-DM1 clinical trials in myotonic dystrophy type 1},
journal = {Neuromuscular Disorders},
year = {2024},
volume = {43},
pages = {104441.536},
doi = {10.1016/j.nmd.2024.07.545}
}
EUVIMED